Litcius/Paper detail

SARS-CoV-2 Vaccination-Induced Transverse Myelitis

Nayha Tahir, Gowthami Koorapati, Sonika Prasad, Hafiz Muhammad Jeelani, Robin Sherchan, Jishna Shrestha, Maryna Shayuk

2021Cureus54 citationsDOIOpen Access PDF

Abstract

While mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. We report a case of transverse myelitis and Bell's palsy after receiving Johnson and Johnson COVID-19 vaccination under the emergency use authorization in a healthy young woman with no past medical history. Other possible etiologies of her symptoms were ruled out, and she was treated successfully with steroids and plasma exchange.

Topics & Concepts

MedicineTransverse myelitisVaccinationCoronavirus disease 2019 (COVID-19)Neuromyelitis opticaImmunizationEtiologyPediatricsMyelitisCoronavirusAdverse effectPoliomyelitisVirologyIntensive care medicineDiseaseImmunologyMultiple sclerosisPathologyInternal medicineAntibodyInfectious disease (medical specialty)Spinal cordPsychiatryPeripheral Neuropathies and DisordersLong-Term Effects of COVID-19Multiple Sclerosis Research Studies
SARS-CoV-2 Vaccination-Induced Transverse Myelitis | Litcius